Plea for action on US healthcare IT
This article was originally published in Clinica
Congress must act this year to ensure the wider adoption of healthcare IT (HIT) across the US, the Senate budget committee was told at its latest hearing.
You may also be interested in...
The fast-dissolving tablet will launch in early March. Its list price is not available but based on pricing for Allergan’s oral anti-CGRP Ubrelvy, ICER has said Biohaven’s rimegepant is likely to be cost-effective.
A surge in Chinese applications for clinical trials for coronavirus treatments, and a fall in patient numbers, are complicating recruitment efforts for the most promising drugs, prompting official moves to tighten study rules.